close
MENU
Tech & Innovation
4 mins to read

Pacific Edge’s Medicare coverage could be regained, analyst says

But a new threat has emerged from proposed FDA regulation.

 

Pacific Edge has opportunity to overturn the Novitas decision.

News this week that the withdrawal of Medicare insurance coverage for Pacific Edge’s Cxbladder tests has been delayed is a win for the company but there are still a wide range of potential outcomes, Craigs research analyst Rob Morrison says.

Novitas, the Medicare Administrative Contractor (MAC)

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Fiona Rotherham Fri, 07 Jul 2023
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Pacific Edge’s Medicare coverage could be regained, analyst says
Tech & Innovation,
99862